Another quarter, another cull for Moderna. The company snuck into its second-quarter earnings report (PDF) that development of an mRNA treatment for IL-2-based autoimmune disorders has ended. Moderna ...

Werewolf Therapeutics is developing a "conditionally activated" interleukin-2 (IL-2) drug for the treatment of stage IV melanoma and metastatic cancers. The drug aims to deliver therapeutic doses of ...

Results from Phase 1a portion of trial show first-in-class α/β biased IL-2 has potential to decouple efficacy and toxicity of IL-2 First dose expansion cohorts in Phase 1b portion of trial will ...

The writing is on the wall at Mural Oncology. Responding to clinical data, the biotech is laying off 90% of its employees and stopping clinical development of its lead program to hunker down and seek ...

Interleukin-2 (IL-2) is a cytokine, a type of immune system signaling molecule, that plays a crucial role in the body's response to microbial infections and in distinguishing between self and non-self ...

Oleg Maddox’s world famous IL-2 Sturmovik series of flight simulators continues to expand. The latest offering, IL-2 1946, adds 36 new planes, four new gigantic maps, over a hundred new ground objects ...